Fu Y - Search Results

1

Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators.

Fu Y, Chang WC, Mark D, Califf RM, Mackenzie B, Granger CB, Topol EJ, Hlatky M, Armstrong PW. Fu Y, et al. Circulation. 2000 Sep 19;102(12):1375-81. doi: 10.1161/01.cir.102.12.1375. Circulation. 2000. PMID: 10993855 Clinical Trial.

2

Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes.

Khadour FH, Fu Y, Chang WC, Ma X, Mark D, Granger CB, Topol EJ, Califf RM, Armstrong PW; GUSTO IIb investigators. Khadour FH, et al. Among authors: fu y. Can J Cardiol. 2003 Mar 15;19(3):257-63. Can J Cardiol. 2003. PMID: 12677281

3

International differences in evolution of early discharge after acute myocardial infarction.

Kaul P, Newby LK, Fu Y, Mark DB, Califf RM, Topol EJ, Aylward P, Granger CB, Van de Werf F, Armstrong PW. Kaul P, et al. Among authors: fu y. Lancet. 2004 Feb 14;363(9408):511-7. doi: 10.1016/S0140-6736(04)15536-0. Lancet. 2004. PMID: 14975612

4

Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.

Kaul P, Armstrong PW, Fu Y, Knight JD, Clapp-Channing NE, Sutherland W, Granger CB, Mark DB; GUSTO-IIb investigators. Kaul P, et al. Among authors: fu y. Can J Cardiol. 2004 Jun;20(8):760-6. Can J Cardiol. 2004. PMID: 15229756 Clinical Trial.

5

Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction.

Chang WC, Kaul P, Fu Y, Westerhout CM, Granger CB, Mahaffey KW, Wallentin L, Van de Werf F, Armstrong PW; ASSENT-3 Investigators. Chang WC, et al. Among authors: fu y. Eur Heart J. 2006 Feb;27(4):419-26. doi: 10.1093/eurheartj/ehi700. Epub 2006 Jan 11. Eur Heart J. 2006. PMID: 16407373

6

ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.

Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, White HD, van 't Hof AW, Van de Werf FJ, Wagner GS, Granger CB, Armstrong PW. Buller CE, et al. Among authors: fu y. Circulation. 2008 Sep 23;118(13):1335-46. doi: 10.1161/CIRCULATIONAHA.108.767772. Epub 2008 Sep 8. Circulation. 2008. PMID: 18779444 Clinical Trial.

7

ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy.

Armstrong PW, Siha H, Fu Y, Westerhout CM, Steg PG, James SK, Storey RF, Horrow J, Katus H, Clemmensen P, Harrington RA, Wallentin L. Armstrong PW, et al. Among authors: fu y. Circulation. 2012 Jan 24;125(3):514-21. doi: 10.1161/CIRCULATIONAHA.111.047530. Epub 2011 Dec 16. Circulation. 2012. PMID: 22179530 Clinical Trial.

8

Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators.

Armstrong PW, Fu Y, Chang WC, Topol EJ, Granger CB, Betriu A, Van de Werf F, Lee KL, Califf RM. Armstrong PW, et al. Among authors: fu y. Circulation. 1998 Nov 3;98(18):1860-8. doi: 10.1161/01.cir.98.18.1860. Circulation. 1998. PMID: 9799205 Clinical Trial.

9

Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators.

Chang WC, Fu Y, Ohman EM, Gupta M, Morris A, Roth SN, Granger CB, Califf RM, Topol EJ, Mark DB, Armstrong PW. Chang WC, et al. Among authors: fu y. Can J Cardiol. 2000 Oct;16(10):1231-9. Can J Cardiol. 2000. PMID: 11064297

10

Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.

Barbash GI, Birnbaum Y, Bogaerts K, Hudson M, Lesaffre E, Fu Y, Goodman S, Houbracken K, Munsters K, Granger CB, Pieper K, Califf RM, Topol EJ, Van De Werf F. Barbash GI, et al. Among authors: fu y. Circulation. 2001 Feb 20;103(7):954-60. doi: 10.1161/01.cir.103.7.954. Circulation. 2001. PMID: 11181469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19,799 results

Search Page